Introduction: More adjuvant treatment options are becoming available for hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) early breast cancer (EBC) based on resu
IntroductionMedical decision making is often guided bydisease-specific outcomes such as life extension or survival. Especially for older adults other outcomes like maintaining independence can be equa
IntroductionMedical decision making is often guided bydisease-specific outcomes such as life extension or survival. Especially for older adults other outcomes like maintaining independence can be equa
The data describes the responses of 113 self identified patient respondents for a discrete choice experiment investigating trade-offs between hypothetical treatments. A pending abstract for the paper
